FDA drops proposed rule on asbestos testing in cosmetics - consumeraffairs.com
FDA has withdrawn its proposed rule on asbestos testing in cosmetics, removing a potential future compliance requirement for cosmetic manufacturers.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on September 1, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetic manufacturers, especially those using talc or other ingredients potentially contaminated with asbestos. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The FDA dropped its proposed rule that would have required testing for asbestos in cosmetics.
Who it affects
Cosmetic manufacturers, especially those using talc or other ingredients potentially contaminated with asbestos.
What you must do
No immediate action required; monitor for future regulatory developments.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Publishes Two Key Guidance Documents on Cosmetics Facility Registration and Product Listing - mcguirewoods.com
- California bill to require full disclosure of diaper chemicals heads to Gov. Newsom for signature - ewg.org
- US FDA 2026 Regulatory Plan: Proposed Ban on Formaldehyde in Hair Products and Fragrance Allergen Labeling for Cosmetics - CIRS Group
- What to Know About the FDA’s Ban of Red Dye No. 3 - University of Utah Health
- Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability